Manila Bulletin
Robredo qualified to be among first recipients of CoronaVac
Presidential spokesperson Harry Roque stated that Vice President Leni Robredo is welcome to receive the Sinovac COVID-19 vaccine.
Roque mentioned that Robredo qualifies for the vaccine as she falls within the 18-59 age range.
The FDA granted Sinovac an emergency use authorization (EUA) for individuals aged 18 to 59.
The first batch of Sinovac vaccines is expected to arrive in the country within a week.
Roque himself expressed willingness to receive the Sinovac vaccine, pending approval from President Rodrigo Duterte.
Robredo's camp previously stated that she would publicly receive a COVID-19 vaccine to boost public confidence.
The Philippine government decided to administer the Sinovac vaccine to "economic front-liners" belonging to the 18 to 59 age group.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Senator "Bong" Go announced that he and President Duterte are willing to get vaccinated in public to demonstrate that vaccination is the only hope against COVID-19.
Read more →
The Philippines commenced its COVID-19 vaccination program on March 1, 2021, using 600,000 Sinovac vaccine doses from China.
+3
Read more →
Around 1.5 million doses of Sinovac's COVID-19 vaccine are anticipated to reach the Philippines, with an initial 600,000 doses donated by the Chinese government expected to arrive on Sunday, February 28.
+2
Read more →
The Philippines' first batch of 600,000 Sinovac vaccines, donated by China, is scheduled to arrive on Sunday, February 28.
+1
Read more →
The FDA clarified that health workers can still choose to receive the Sinovac vaccine despite the agency's recommendation against its use for them due to lower efficacy rates.
+1
Read more →